Fritextsökning
Innehållstyper
-
We are poor lobbyists
I doubt there has ever been a really well thought out Scandinavian campaign with intentions to really change attitudes among both the public and politicians.
-
45 miljoner till biologiska läkemedel
Genom ett nytt forskningsprogram vill Vinnova och Vetenskapsrådet främja svensk utveckling och tillverkning av biologiska läkemedel.
-
Changing e-solutions for clinical trials
Social media and personalized medicine are two factors that will have a great impact on the design and IT-solutions for clinical trials. Unithink is an upcoming...
-
The winner of the race
She learned how to work hard at an early age and her devotion has certainly paid off. Whether it is field running or running a company, the key to success is fo...
-
Framåt för Sobi
Efter gårdagens kvartalsrapport som slog förväntningarna får bolagets läkemedel Alprolix godkänt i Schweiz.
-
Han tar plats i den virtuella ledningsgruppen
Advokaten Stefan Wendén tar plats i forskningsparken Medeons första virtuella ledningsgrupp.
-
Han ska ta in kapital åt tillväxtbolagen
För att öka tillgången på externt kapital för tillväxtbolagen i Sahlgrenska Science Park inrättas en ny tjänst.
-
BMAs: Run your own business
After graduation you must decide: be an employee or start your own business. This is not really the situation for BMAs today, but a collaborative project betwee...
-
Oasmia får FDA-ok för djurläkemedel
Godkännandet ger bolaget ekonomisk stabilitet, menar vd.
-
Per Hammargren, Sales Director, ICU Scandinavia AB
Why are you going to Scanlab and Biotech Forum?
-
One-step cleaning system for use in clean rooms
The Micronswep cleaning system from Berendsen is a single action cleaning system developed for use in clean rooms.
-
Rapid system for surface hygiene monitoring
The Clean-Trace Surface Testing Instruments are a rapid solution to monitor biological contamination on surfaces in real time to help customers manage their cle...
-
Lägger ner arbetet med hjärtinfarkt
Efter negativa resultat från fas III-studien Circus avslutar Neurovive sin utveckling mot akut hjärtinfarkt.
-
New study of toxins and heart disease
Is there a correlation between exposure to hormone interfering environmental toxins and increased risk of developing cardiovascular disease? A new patient study...
-
Go ahead for leg wound study
Tripep starts a phase II-study of their wound healing joint venture project.
-
Happy exhibitors!
There were fewer vistors this year but most exhibitors are content.
-
"An open mind is the key to successful meetings"
Meeting in person is irreplaceble when it comes to finding a new partner. Johan Ohlsson at Venture Valuation is happy with his meetings at Biotech Forum so far ...
-
Dupont gets new business manager
The Swedish API manufacturer Dupont Chemoswed has appointed a new business development manager.
-
Collaboration brings next generation drugs
Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.
-
Acadia drug awarded
Acadia Pharmaceutical has got an award for a new treatment against Parkinson's disease.
-
Prenatal testing breakthrough
For the first time specific gene expression information from fetal cells isolated from maternal blood samples is available.
-
Partnering offer for scientists and medics
For the first time in the history of Biotech Forum, scientists and medics are invited to join the partnering event. I
-
Svårt att kommersialisera akademisk forskning
Det som skulle bli en kassako för universiteten har slutat i rejäla underskott. Att göra affärer av life science-upptäckter vid svenska lärosäten har visat sig ...
-
Anything is measurable
At the seminar "Du är vad jag mäter - hjärnans kemi i ett provrör", Jonas Bergquist, professor of analytical chemistry and neurochemistry, will dig deep into th...
BREAKING